Profile and Outcomes of COVID-19 Infection in Pediatric Patients with and without Cancer: A Case–Control Study

Objectives Pediatric patients with cancer are considered a vulnerable population to the ill effects of coronavirus disease 2019 (COVID-19). We hereby studied the difference between clinical characteristics, lab parameters, and outcomes of COVID-19 among children suffering from cancer and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Puneet Kaur Sahi, Varun Kumar, Arpita Gupta, Mampy Das, Priyanka Meena, Divyanshi Divyanshi
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2025-04-01
Series:	Indian Journal of Medical and Paediatric Oncology
Subjects:	SARS-CoV-2 pediatric cancer hematological malignancy risk factors severe disease solid tumors
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786162
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COVID-19 Vaccination in Patients with Hematological Malignances
by: Massimo Franchini, et al.
Published: (2025-04-01)

Post‐COVID immunity in patients with solid tumor or hematological malignancies treated with SARS‐CoV‐2 monoclonal antibodies
by: Gilberto Sabino‐Santos, et al.
Published: (2024-12-01)

Cutaneous Manifestations of Pediatric Hematological Malignancies: A Narrative Review
by: Ananya Pramanik, et al.
Published: (2025-04-01)

COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS
by: Federico Mercolini, et al.
Published: (2022-01-01)

COVID-19 in Brazilian Pediatric Patients: A Retrospective Cross-Sectional Study with a Predictive Model for Hospitalization
by: Ana Paula Pacheco, et al.
Published: (2024-08-01)

Clinical characteristics and prognosis of SARS-CoV-2 infection in children with hematological malignancies: A multicenter, retrospective study in China
by: Weilin Wang, et al.
Published: (2024-11-01)

Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer
by: K.L. Juliëtte Schmidt, et al.
Published: (2024-12-01)

Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress
by: Huageng Huang, et al.
Published: (2024-12-01)

SARS-CoV-2 Variants and Their Impact on Pediatric COVID-19: Clinical Manifestations and Hematological Profiles
by: Konstantinos Paris Trempelis, et al.
Published: (2025-02-01)

Histopathological Spectrum and Immunohistochemistry Expression of Pediatric Solid Malignant Tumors: An Observational Study
by: Bhumika Patel, et al.
Published: (2025-01-01)

EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA
by: Araya Satdhabudha, et al.
Published: (2022-04-01)

Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report
by: Nadia Bouhamdani, et al.
Published: (2025-06-01)

Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China
by: Jun Li, et al.
Published: (2024-11-01)

Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study
by: Şengül Çağlayan, et al.
Published: (2024-02-01)

Statistical analysis of hematological and biochemical parameters in SARS-CoV-2 infected patients across diverse populations: a cross-sectional observational study
by: S. Qurat ul Ain, et al.
Published: (2025-07-01)

Trends of Cardiac Complaints in Pediatric and Young Adult Populations During the COVID-19 Pandemic
by: Emily M. Ferraro, et al.
Published: (2025-04-01)

The Role of Comorbidities in COVID-19 Severity
by: Sandra König, et al.
Published: (2025-07-01)

Prognostic factors of COVID-19 severity and mortality in the Yucatecan ethnic of México contrast with other populations
by: Gilma Guadalupe Sánchez-Burgos, et al.
Published: (2023-04-01)

Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
by: Delma J. Nieves, et al.
Published: (2025-03-01)

Respiratory microbiome alterations, coinfections and virus intra-host evolution in a persistently active SARS-CoV-2 infection
by: Lučka Boltežar, et al.
Published: (2025-07-01)

Clinical Manifestations of Acute COVID-19 in Previously Healthy Pediatric Patients Diagnosed by Rapid Antigen Screening in a Community-Based, Outpatient Primary Care Pediatrics Practice
by: Stanley Calderwood, et al.
Published: (2024-11-01)

Clinical and Paraclinical Peculiarities of SARS-CoV-2 and Influenza Infections in Children: A Comparative Study
by: Maria Oana Săsăran, et al.
Published: (2025-05-01)

Impact of Cancer Subtype and Cancer Therapy Exposures on SARS‐CoV‐2 Outcomes in the Omicron and Subvariant Era
by: Katelyn M. Atkins, et al.
Published: (2025-07-01)

Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID)
by: Roger Mallol, et al.
Published: (2025-02-01)

Diagnostic accuracy of SARS-CoV-2 antigen test in the pediatric population: A systematic review and meta-analysis
by: Cheng-Chieh Chen, et al.
Published: (2023-05-01)

Impact of SARS-CoV-2 variants on COVID-19 symptomatology and severity during five waves
by: Bruno Belmonte Martinelli Gomes, et al.
Published: (2024-11-01)

Pediatric Hematology : Oncology Secrets /
by: Weiner, Michael A.
Published: (2002)

Virus-specific humoral immune response in Bulgarian COVID-19 patients with varying disease severity
by: Evelina Shikova, et al.
Published: (2023-12-01)

Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study
by: Flavia Petrucci, et al.
Published: (2025-02-01)

Handbook of Pediatric Hematology and Oncology : Children's Hospital & Research Center Oakland /
by: Hastings , Caroline A.
Published: (2012)

Long Term Effect of Post-Covid-19 Syndrome on Hematological Parameters in Iraqi People
by: Sara Basim Zwain, et al.
Published: (2024-06-01)

Mortality from Coronavirus (Covid) SARS-CoV-2 in Oncological Patients
by: Hoyos-Pulgarín, Julián Andrés, et al.
Published: (2025-04-01)

Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
by: María Camila Sossa-Alarcón, et al.
Published: (2025-03-01)

Blood Group Type and COVID-19 Severity at Tertiary Care Centre, Nepal: An Observational Study
by: Nabin Rauniyar, et al.
Published: (2025-07-01)

The clinical impact of prolonged steroid therapy in severe COVID-19 patients: a retrospective cohort study with propensity score matching
by: Jaijun Han, et al.
Published: (2025-05-01)

Can the novel coronavirus be transmitted via RNAs without protein capsids?
by: Zhongneng Xu
Published: (2020-09-01)

Hemato-oncological outpatient care in medical education: a German pilot-project
by: Marie Forster, et al.
Published: (2025-05-01)

HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY
by: Stefano Botti, et al.
Published: (2021-01-01)

Seroprevalence of SARS-CoV-2 in Children Admitted to a Pediatric Ward of an Urban Hospital
by: Rama Kaja, et al.
Published: (2022-12-01)

The health experience of children, adolescents and their families during the COVID-19 pandemic: an exploratory qualitative study in pediatric homecare
by: Clélia Zahnd, et al.
Published: (2025-06-01)